Skip to main content
Log in

Changes in the Concentration of Monocytic Chemotaxic Protein-1 in Patients with Unstable Angina Treated with Arixtra

  • Experimental Methods for Clinical Practice
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The time course of inflammatory reaction markers in the blood of patients with unstable angina was studied during therapy including arixtra. Plasma concentration of monocytic chemotaxic protein-1 (MCP-1) decreased on days 2 and 3 in patients receiving arixtra and a trend to an increase in MCP-1 concentration was observed on day 7 after the drug was discontinued. After 1 month, MCP-1 level decreased in all patients. The concentration of highly sensitive C-reactive protein also decreased 1 month after the disease onset; no changes in the concentrations of IL-8 and IL-2 receptor α-subunit were detected during these periods. It seems that arixtra is characterized by an anti-inflammatory effect manifesting by reduction of plasma chemokine MCP-1 concentration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. N. B. Kukhtina, T. I. Arefieva, A. M. Arefieva, et al., Ter. Arkh., No. 4, 63–69 (2008).

  2. S. I. Provatorov, T. I. Arefieva, N. B. Kukhtina, et al., Ibid., No. 6, 66–69 (2006).

  3. M. Baggiolini, Nature, 392, 565–568 (1998).

    Article  PubMed  CAS  Google Scholar 

  4. J. W. Celie, R. H. Beelen, and J. van den Born, Front Biosci., 14, 4932–4949 (2009).

    Article  PubMed  Google Scholar 

  5. J. A. de Lemos, D. A. Morrow, M. A. Blazing, et al., J. Am. Coll. Cardiol., 50, No. 22, 2117–2124 (2007).

    Article  PubMed  Google Scholar 

  6. R. D. Frank, G. Schabbauer, T. Holscher, et al., J. Thromb. Haemost., 3, No. 3, 531–540 (2005).

    Article  PubMed  CAS  Google Scholar 

  7. C. Gonzalez-Quesada and N. G. Frangogiannis, Curr. Atheroscler. Rep., 11, No. 2, 131–138 (2009).

    Article  PubMed  CAS  Google Scholar 

  8. U. Ikeda, T. Ito, and K. Shimada, Clin. Cardiol., 24, No. 11, 701–704 (2001).

    Article  PubMed  CAS  Google Scholar 

  9. S. S. Jolly, D. P. Faxon, K. A. Fox, et al., J. Am. Coll. Cardiol., 54, No. 5, 468–476 (2009).

    Article  PubMed  CAS  Google Scholar 

  10. H. Kervinen, M. Mänttäri, M. Kaartinen, et al., Am. J. Cardiol., 94, No. 8, 993–996 (2004).

    Article  PubMed  CAS  Google Scholar 

  11. F. Mach, A. Sauty, A. S. Iarossi, et al., J. Clin. Invest., 104, No. 8, 1041–1050 (1999).

    Article  PubMed  CAS  Google Scholar 

  12. K. Olanders, A. Börjesson, X. Zhao, et al., Acta Anaesthesiol. Scand., 49, No. 4, 517–524 (2005).

    Article  PubMed  CAS  Google Scholar 

  13. A. Ozeren, M. Aydin, M. Tokac, et al., Mediators Inflamm., 12, No. 6, 361–365 (2003).

    Article  PubMed  Google Scholar 

  14. D. J. Tyrrell, A. P. Horne, K. R. Holme, et al., Adv. Pharmacol., 46, 151–208 (1999).

    Article  PubMed  CAS  Google Scholar 

  15. Y. Yu, M. D. Sweeney, O. M. Saad, et al., J. Am. Soc. Mass Spectrom., 17, No. 4, 524–535 (2006).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. V. Potekhina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 150, No. 11, pp. 590–593, November, 2010

Rights and permissions

Reprints and permissions

About this article

Cite this article

Potekhina, A.V., Arefieva, T.I., Krasnikova, T.L. et al. Changes in the Concentration of Monocytic Chemotaxic Protein-1 in Patients with Unstable Angina Treated with Arixtra. Bull Exp Biol Med 150, 656–658 (2011). https://doi.org/10.1007/s10517-011-1215-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-011-1215-1

Key Words

Navigation